220 related articles for article (PubMed ID: 19754461)
1. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
Bazinet RP
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1104-9. PubMed ID: 19754461
[TBL] [Abstract][Full Text] [Related]
2. Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?
Rao JS; Lee HJ; Rapoport SI; Bazinet RP
Mol Psychiatry; 2008 Jun; 13(6):585-96. PubMed ID: 18347600
[TBL] [Abstract][Full Text] [Related]
3. Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism.
Lee HJ; Rao JS; Rapoport SI; Bazinet RP
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):239-46. PubMed ID: 18042366
[TBL] [Abstract][Full Text] [Related]
4. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.
Rapoport SI
ACS Chem Neurosci; 2014 Jun; 5(6):459-67. PubMed ID: 24786695
[TBL] [Abstract][Full Text] [Related]
5. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
Rapoport SI; Bosetti F
Arch Gen Psychiatry; 2002 Jul; 59(7):592-6. PubMed ID: 12090811
[TBL] [Abstract][Full Text] [Related]
6. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder.
Bazinet RP; Rao JS; Chang L; Rapoport SI; Lee HJ
Biol Psychiatry; 2006 Mar; 59(5):401-7. PubMed ID: 16182257
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.
Bazinet RP; Weis MT; Rapoport SI; Rosenberger TA
Psychopharmacology (Berl); 2006 Jan; 184(1):122-9. PubMed ID: 16344985
[TBL] [Abstract][Full Text] [Related]
8. Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder.
Duncan RE; Bazinet RP
Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):130-8. PubMed ID: 20145439
[TBL] [Abstract][Full Text] [Related]
9. Bipolar disorder and mechanisms of action of mood stabilizers.
Rapoport SI; Basselin M; Kim HW; Rao JS
Brain Res Rev; 2009 Oct; 61(2):185-209. PubMed ID: 19555719
[TBL] [Abstract][Full Text] [Related]
10. New approaches in managing bipolar depression.
Keck PE; McElroy SL
J Clin Psychiatry; 2003; 64 Suppl 1():13-8. PubMed ID: 12625800
[TBL] [Abstract][Full Text] [Related]
11. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
Chengappa KN; Gershon S; Levine J
Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
[TBL] [Abstract][Full Text] [Related]
12. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Dunner DL
J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
[TBL] [Abstract][Full Text] [Related]
13. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
14. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
[TBL] [Abstract][Full Text] [Related]
15. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
16. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
Bourin M; Prica C
Neurosci Biobehav Rev; 2007; 31(6):963-75. PubMed ID: 17462734
[TBL] [Abstract][Full Text] [Related]
17. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat.
Bazinet RP; Rao JS; Chang L; Rapoport SI; Lee HJ
Psychopharmacology (Berl); 2005 Oct; 182(1):180-5. PubMed ID: 15986187
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds.
Potter WZ; Ketter TA
Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S51-6. PubMed ID: 8500079
[TBL] [Abstract][Full Text] [Related]
19. Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder.
Lee HJ; Rao JS; Chang L; Rapoport SI; Bazinet RP
Psychopharmacology (Berl); 2007 Sep; 193(4):467-74. PubMed ID: 17487474
[TBL] [Abstract][Full Text] [Related]
20. Mood-stabilizers target the brain arachidonic acid cascade.
Rao JS; Rapoport SI
Curr Mol Pharmacol; 2009 Jun; 2(2):207-14. PubMed ID: 20021459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
